Home

DiaMedBase 

Diabetes Medicinal Plant Database

Browse    A B C D E F G H I J K L M N O P Q R S T U V W X Y Z     Plants List
Abelmoschus
Abies
Abroma
Acacia
Acanthopanax
Acer
Achillea
Achyranthes
Achyrocline
Acosmium
Acourtia
Adhatoda
Aegle
Agaricus
Aglaonema
Agrimony
Ajuga
Alchemilla
Allium
Aloe
Anacardium
Andrographis
Anemarrhena
Angylocalyx
Annona
Apocynum
Aralia
Arctium
Arctostaphylos
Areca
Arfazetin
Artemisia
Artocarpus
Asteracanthus
Astragalus
Averrhoa
Azadirachta
Azorella


 
DiaMedBase ID   DMPAo054
Medicinal Plant   Anacardium occidentale
Plant part(s)   Whole plant
Objective  

To study the effect of Anacardium occidentale aqueous extract against streptozotocin-induced diabetes in rats

Journal Source   J Ethnopharmacol. 1998; 62(2):95-99
Title   Protective role of Anacardium occidentale extract against streptozotocin-induced diabetes in rats
Authors   Kamtchouing P, Sokeng SD, Moundipa PF, Watcho P, Jatsa HB, Lontsi D
Address  

Department of Animal Biology and Physiology, Faculty of Science, University of Yaounde 1, Cameroon

Abstract  

The protective effect of Anacardium occidentale aqueous extract against streptozotocin-induced diabetes was evaluated in rats. The rats were treated with 175 mg/kg of the extract per os, twice daily; beginning 2 days before streptozotocin (STZ) injection. A total of 3 days after STZ administration, there was a 48% increase in blood glucose level in pretreated rats, compared with a 208% increase in diabetic control rats treated with STZ alone. Furthermore, these pretreated animals presented no glycosuria, a normal weight gain and a non significant increase in food and fluid intake at the end of the treatment compared with the normal control. Diabetic control animals showed a positive glycosuria, body weight loss, a real polyphagia and polydypsia. These results indicate the protective role of Anacardium occidentale extract against the diabetogenic action of STZ.

Diseases   Disease Link
DiaMedBase ID   DMPAo055
Medicinal Plant   Burdock (Arctium lappa), cashew (Anacardium occidentale), dandelion (Taraxacum officinale), elder (Sambucus nigra), fenugreek (Trigonella foenum-graecum), guayusa (Ilex guayusa), hop (Humulus lupulus), nettle (Urtica dioica), cultivated mushroom (Agaricus bisporus), periwinkle (Catharanthus roseus), sage (Salvia officinale), and wild carrot (Daucus carrota)
Plant part(s)   Whole plant
Objective   To study the glycemic effect
Journal Source   Diabetes Res., 1989; 10(2):69-73
Title   Glycaemic effects of traditional European plant treatments for diabetes. Studies in normal and streptozotocin diabetic mice
Authors   Swanston-Flatt SK, Day C, Flatt PR, Gould BJ, Bailey CJ
Address   Department of Biochemistry, University of Surrey, Guildford, UK
Abstract   Twelve plants used for the traditional treatmessnt of diabetes mellitus in northern Europe were studied using normal and streptozotocin diabetic mice to evaluate effects on glucose homeostasis. The plants were administered in the diet (6.25% by weight) and/or as decoctions or infusions in place of drinking water, to coincide with the traditional method of preparation. Treatment for 28 days with preparations of burdock (Arctium lappa), cashew (Anacardium occidentale), dandelion (Taraxacum officinale), elder (Sambucus nigra), fenugreek (Trigonella foenum-graecum), guayusa (Ilex guayusa), hop (Humulus lupulus), nettle (Urtica dioica), cultivated mushroom (Agaricus bisporus), periwinkle (Catharanthus roseus), sage (Salvia officinale), and wild carrot (Daucus carrota) did not affect the parameters of glucose homeostasis examined in normal mice (basal plasma glucose and insulin, glucose tolerance, insulin-induced hypoglycaemia and glycated haemoglobin). After administration of streptozotocin (200 mg/kg) burdock and nettle aggravated the diabetic condition, while cashew, dandelion, elder, fenugreek, hop, periwinkle, sage and wild carrot did not significantly affect the parameters of glucose homeostasis studied (basal glucose and insulin, insulin-induced hypoglycaemia, glycated haemoglobin and pancreatic insulin concentration). Guayusa and mushroom retarded the development of hyperglycaemia in streptozotocin diabetes and reduced the hyperphagia, polydipsia, body weight loss, and glycated haemoglobin. Mushroom also countered the initial reduction in plasma insulin and the reduction in pancreatic insulin concentration, and improved the hypoglycaemic effect of exogenous insulin. These studies suggest the presence of potentially useful antidiabetic agents in guayusa and mushroom.
Diseases   Disease Link
 

               Copyright © 2006 ProGene Biosciences
            Last modified: March, 2006
             info@progenebio.in